Cite
MLA Citation
Carlo Gambacorti‐Passerini et al.. “Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up.” American journal of hematology, vol. 89, no. 7, n.d., pp. 732–742. http://access.bl.uk/ark:/81055/vdc_100024867531.0x00005d